-
CD38-specific chimeric antigen receptor expressing natural killer KHYG-1 cells: A proof of concept for an "Off the Shelf" therapy for multiple myeloma
Stikvoort, A., van der Schans, J., Sarkar, S., Poels, R., Ruiter, R., Naik, J., Yuan, H., de Bruijn, J. D., van de Donk, N. W. C. J., Zweegman, S., Themeli, M., Groen, R., O'Dwyer, M. & Mutis, T., Jul 2021, In: HemaSphere. e596.Research output: Contribution to journal › Article* › Academic › peer-review
-
Preclinical rationale for targeting the PD‐1/PD‐L1 axis in combination with a CD38 antibody in multiple myeloma and other CD38‐ positive malignancies
Verkleij, C. P. M., Jhatakia, A., Broekmans, M. E. C., Frerichs, K. A., Zweegman, S., Mutis, T., Bezman, N. A. & van de Donk, N. W. C. J., 1 Dec 2020, In: Cancers. 12, 12, p. 1-20 20 p., 3713.Research output: Contribution to journal › Article* › Academic › peer-review
-
Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors
Eeltink, C. M., Lissenberg-Witte, B. I., Incrocci, L., Braamse, A. M. J., Visser, O., Zijlstra, J., Verdonck-de Leeuw, I. M. & Zweegman, S., Sept 2020, In: SEXUAL MEDICINE. 8, 3, p. 428-435 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
